Compare NEO & CC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NEO | CC |
|---|---|---|
| Founded | 2001 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Precision Instruments | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.3B |
| IPO Year | 2008 | 2014 |
| Metric | NEO | CC |
|---|---|---|
| Price | $17.38 | $15.30 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 9 |
| Target Price | $13.38 | ★ $20.11 |
| AVG Volume (30 Days) | 1.6M | ★ 2.0M |
| Earning Date | 04-28-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 1.33% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $6,638,000,000.00 |
| Revenue This Year | $10.63 | $6.15 |
| Revenue Next Year | $9.73 | $5.95 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 7.36 |
| 52 Week Low | $7.07 | $10.44 |
| 52 Week High | $19.76 | $28.67 |
| Indicator | NEO | CC |
|---|---|---|
| Relative Strength Index (RSI) | 58.99 | 45.57 |
| Support Level | $15.72 | $14.45 |
| Resistance Level | $19.76 | $16.44 |
| Average True Range (ATR) | 0.83 | 0.58 |
| MACD | -0.03 | 0.12 |
| Stochastic Oscillator | 42.57 | 46.82 |
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
The Chemours Co is a provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets including coatings, plastics, refrigeration, air conditioning, paints and coatings, plastics, transportation, semiconductor, and others. The company's operating segments include Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment is a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency, and protection across a variety of applications. Geographically, the company derives a majority of its revenue from North America.